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ABSTRACT The draft genome sequences of two Nocardia farcinica strains isolated
from two patients with cystic fibrosis (CF), resistant to trimethoprim/sulfamethoxa-
zole and linezolid, are reported here. The estimated genome sizes were 5.8 Mb with
a 70.63% GC content. Transposases from Tn916 were detected, but not 23S rRNA
mutation (G2576T) related to linezolid resistance.
Nocardia spp. are environmental bacteria that cause pulmonary infections similar totuberculosis, and even disseminated disease (1, 2). Nocardia farcinica causes invasive
infections with cerebral involvement (55%) and high mortality (35%) (1, 3). In Spain,
resistance to trimethoprim/sulfamethoxazole (the cornerstone of treatment) in N. farcinica
runs at 45% (4). Linezolid, with excellent bioavailability, provides an efficient alternative (1,
5). From childhood, patients with cystic fibrosis (CF) suffer frequent lung infections. From
these patients, two N. farcinica strains (drug pattern type V [6]) highly resistant to trim-
ethoprim/sulfamethoxazole and linezolid (MICs 32:608 and 256 g/mL, respectively),
were sequenced for a better understanding of their genetic background.
Paired-end libraries (Nextera-XT DNA library preparation kit, Illumina 1.9), were
adapted and sequenced at 2  150 using Illumina NextSeq500. After quality control
analysis involving fastQC v0.11.3 (http://www.bioinformatics.babraham.ac.uk/projects/
fastqc/) and Trimmomatic v0.36 software (7), 3.1 million to 3.6 million paired-end reads
of 50 to 151 bp were retrieved. Read assembly was performed using SPAdes v3.8.0
software (8) (kmer  77), and the quality was evaluated using QUAST software (9).
The draft genomes of the strains, named CNM20080921 and CNM20091955, were both
5.8 Mbp long and had a GC content of 70.63% (178 and 113 contigs of 500 bp;
maximum, 674,734 and 1,141,487 bp; N50 value, 167,048 and 453,514 bp). Analysis using
ANI software (10) revealed them to show 99.98% sequence similarity, and 99.28% similarity
to N. farcinica NCTC11134 (GenBank accession number, NZ_LN868938). The assembled
sequences were annotated using Prokka 1.12-beta software (11), which predicted 6,502 and
6,455 genes (6,428 and 6,381 protein-coding genes and 427 and 419 signal peptides, respec-
tively), and 6 rRNAs, 67 tRNAs, and 1 transfer-messenger RNA (tmRNA) for both strains.
The following potential resistance genes (https://ardb.cbcb.umd.edu/, http://
nocardia.nih.go.jp) were detected in both strains: bmr, stp, marR, mtdL, norM, emrB,
emrY, FAR-1, ampC, aacA-aphD, aph(3=), ant1, neo, fstH, htpX, murA, ermH, tetA, tetC, tetR,
mtdH, dfrA26, vanW, bac, qacA, sugE, acr3, ohrA, drrA, drrB, drrC, carA, merR, and yfmO;
rmlA was detected in CNM20091955 only. Detected resistant genes by PCR sequencing
of boiled extract of both strains (12), e.g., int1-3, sul1-2, ermTR, ermB, and tetO (and mefO
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for CNM20080921), were not detected by srst2 (13) and ARGANNOT (14) software (only
int1, clmA, and FAR-1 were detected). Neither of the two 23S rRNA copies showed the
G2576T mutation (Escherichia coli numbering) allowing linezolid resistance. However, one
allele of CNM20080921 showed the change G2608A. Mobile element-related sequences,
such as IS5376/IS6110, tnpR (resolvase) guaA (integration hot spot), three IS3-family trans-
posases, and two transposases from Tn916, were identified in both strains.
Similar virulence contents were detected such as mammalian cell entry protein,
ESX-1, and others (fbpA, fbpB, fbpC, sodC, katA, katE, katG, ideR, nbtB, nbtD, nbtE, nbtF,
nbtG, nbtS, aphC, aphD, narG, oxyR, ndk, ptpA, tlyA, and tlyC) (15). The biosynthetic gene
clusters for CNM20080921 and CNM20091955 were 7 and 9 nonribosomal peptide
synthases, 4 and 5 polyketide synthases, 5 terpene cyclases, and ectoine and nocobac-
tin genes, respectively (16). Clustered regularly interspaced short palindromic repeats
(CRISPR) (12 and 11, respectively) were found in each one. In both strains, the same
incomplete prophage (7.4 Kb, 71.39% GC) was identified (17).
Given their exposure to viral/bacterial infections and frequent antimicrobial treat-
ment, the pulmonary microbiomes of patients with CF are fragile. If lung transplanta-
tion is to be successful in such patients, the surveillance of Nocardia species is needed
(see reference 18).
Accession number(s). This whole-genome shotgun project has been deposited at
DDBJ/ENA/GenBank under the accession numbers NXEH00000000 and NXEG00000000
for CNM20080921 and CNM20091955, respectively. The versions described in this paper
are versions NXEH01000000 and NXEG01000000.
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